Adigens Health
Adigens Health partners with life sciences companies to generate robust real-world evidence that withstands regulatory, payer, and clinical scrutiny. The firm applies advanced causal inference methods and multidisciplinary expertise to services such as target trial emulation, RWE strategy for health technology agencies, and RWE-driven trial design covering endpoints, dose selection, and comparators.
- Data & Analytics
- Digital Health
- Healthcare Technology
- Software Only
Funding
Founders
Founder details are not available yet.
Product
Problem
Life sciences companies face increasing pressure to generate robust real-world evidence that satisfies regulatory, payer, and clinical review standards, yet traditional trial designs often fail to address these demands efficiently. Fragmented data sources and suboptimal analytical methods can delay asset development, increase costs, and create uncertainty in market access decisions.
Solution
Adigens Health partners with life sciences companies to harness insights and real-world evidence, expediting clinical development and preparing for successful asset launch. The firm combines advanced causal inference methodology with multidisciplinary expertise across epidemiology, biostatistics, clinical development, medical affairs, and market access. By cutting through complexity and applying rigorous methodology, Adigens Health delivers solutions that hold up under regulatory, payer, and clinical scrutiny. Services include target trial emulation, RWE strategy for regulators and health technology agencies, and RWE-driven trial design covering endpoints, dose selection, and comparators.
Target Audience
Primary customers are biopharmaceutical and life sciences companies preparing for regulatory submissions, health technology assessments, or market access negotiations, particularly those needing robust real-world evidence for clinical development and asset launch.
Features
- Target trial emulation with real-world data design, analysis, and external control arm construction
- RWE strategy development tailored for regulatory submissions and health technology assessment agencies
- RWE-driven trial design optimization including endpoint selection, dose selection, and comparator choices
- Advanced causal inference methods that match decision standards for regulatory and payer acceptance
- Multidisciplinary team spanning epidemiology, biostatistics, clinical development, medical affairs, and market access
- Study design and analysis built specifically for scrutiny and adoption in high-stakes review processes